Workflow
山东玻纤(605006) - 2024 Q1 - 季度财报
605006SDF(605006)2024-04-23 13:48

Financial Performance - The company's operating revenue for Q1 2024 was CNY 514,607,850.91, representing a decrease of 18.09% compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of CNY 85,199,301.16, a decline of 196.28% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of CNY 87,580,174.89, down 694.84% from the previous year[5]. - The basic earnings per share were CNY -0.14, reflecting a decline of 193.33% year-on-year[5]. - The diluted earnings per share were also CNY -0.14, showing a decrease of 193.33% compared to the same period last year[5]. - The weighted average return on equity was -3.10%, a decrease of 6.17 percentage points year-on-year[5]. - The company reported a net loss in Q1 2024 compared to a profit in Q1 2023, indicating a significant shift in financial performance[18]. - The net profit for Q1 2024 was a loss of CNY 85.20 million, compared to a profit of CNY 88.49 million in Q1 2023, indicating a significant decline in profitability[20]. Cash Flow - The net cash flow from operating activities was CNY 91,248,428.34, a decrease of 33.64% compared to the same period last year[5]. - Cash inflows from operating activities totaled CNY 422.03 million in Q1 2024, slightly up from CNY 420.02 million in Q1 2023[23]. - The net cash flow from operating activities decreased to CNY 91.25 million in Q1 2024 from CNY 137.50 million in Q1 2023, a decline of approximately 33.6%[23]. - The company reported cash outflows from investing activities of CNY 281.38 million in Q1 2024, compared to CNY 77.86 million in Q1 2023, indicating increased investment activity[25]. - The net cash flow from financing activities was CNY 164.08 million in Q1 2024, a recovery from a negative cash flow of CNY -221.54 million in Q1 2023[25]. - The total cash and cash equivalents at the end of Q1 2024 were CNY 616.99 million, an increase from CNY 466.46 million at the end of Q1 2023[25]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 6,810,721,716.80, an increase of 2.46% from the end of the previous year[6]. - The total current assets reached RMB 2,234,657,869.06, an increase of 8.8% from RMB 2,052,976,347.79 at the end of 2023[14]. - Total liabilities amounted to RMB 4,104,719,771.76, up from RMB 3,859,027,780.51, indicating an increase of 6.4%[16]. - The company's total equity decreased to RMB 2,706,001,945.04 from RMB 2,788,180,969.16, a decline of 2.9%[16]. - The total assets increased to CNY 3,780,005,937.71 in Q1 2024 from CNY 3,631,120,282.45 in Q1 2023, reflecting a growth of 4.1%[29]. - The total liabilities rose to CNY 1,716,790,540.61 in Q1 2024, up from CNY 1,518,273,094.11 in Q1 2023, indicating an increase of 13.1%[29]. - The company's total equity decreased to CNY 2,063,215,397.10 in Q1 2024 from CNY 2,112,847,188.34 in Q1 2023, a decline of 2.3%[29]. Inventory and Receivables - Accounts receivable decreased to RMB 106,614,018.55 from RMB 74,700,428.15, showing an increase of 42.7%[14]. - Inventory increased to RMB 297,279,106.93, up from RMB 283,220,846.07, representing a growth of 5.0%[14]. - The company's inventory increased to CNY 143,171,975.58 in Q1 2024 from CNY 128,031,504.63 in Q1 2023, representing a growth of 11.8%[29]. - The company reported a significant increase in other receivables, which rose to CNY 700,581,603.25 in Q1 2024 from CNY 629,765,535.08 in Q1 2023, an increase of 11.3%[29]. Research and Development - Research and development expenses rose to CNY 22.99 million in Q1 2024, up from CNY 19.98 million in Q1 2023, reflecting a focus on innovation[19]. - Research and development expenses for Q1 2024 were CNY 11,885,118.20, compared to CNY 9,607,812.86 in Q1 2023, marking a 23.6% increase[32]. Tax and Other Expenses - The company experienced a significant increase in tax expenses, with CNY 3.85 million in Q1 2024 compared to CNY 18.02 million in Q1 2023, indicating changes in tax obligations[19]. Accounting Standards - The company did not apply new accounting standards or interpretations starting from 2024[36].